Foray Bioscience, a Cambridge, MA-based startup that deploys plant-based biomanufacturing to protect and restore natural ecosystems, raised $3M in Seed funding.
The round was led by ReGen Ventures. Additional investors included The Engine Ventures, Susquehanna Sustainable Investments, Understorey Ventures, Superorganism, and others.
The company intends to use the funds to expand its predictive plant cell culture platform, launch product development engagements with select partners, and expand its Boston-based team.
Led by CEO and Founder Dr. Ashley Beckwith, Foray deploys plant-based biomanufacturing to protect and restore natural ecosystems. The company’s novel technology uses plant cells cultivated outside of the plant to produce a variety of goods more efficiently: from molecules, to materials, and even seeds.
FinSMEs
25/06/2024